Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

Share Repurchase Programme - 2026

16 Jan 2026 07:01

RNS Number : 1335P
Polar Capital Holdings PLC
16 January 2026
 

16 January 2026

Polar Capital Holdings plc ("Polar Capital" or the "Company")

Share Repurchase Programme - 2026

Polar Capital announces that the Board of Directors has approved a share repurchase programme to return up to a maximum aggregate amount of ÂĢ15,000,000 to the Company's shareholders via open market purchases of the Company's ordinary shares of 2.5 pence each (the "Ordinary Shares") on the London Stock Exchange (the "Programme").

About the Programme

· The purpose of the Programme is to reduce the share capital of the Company and the Programme will be financed through existing cash resources.

 

· The Company has appointed Deutsche Bank AG, London Branch (trading for these purposes as Deutsche Numis) ("Deutsche Numis") to independently manage the Programme to repurchase Ordinary Shares on its behalf.

 

· The aggregate number of Ordinary Shares acquired by the Company pursuant to the Programme shall not exceed the maximum number of Ordinary Shares which the Company is authorised to purchase pursuant to the authority obtained at the Company's AGM to repurchase up to a maximum 15,225,099 Ordinary Shares ("General Authority") that was approved at the 2025 AGM on 25 September 2025.

 

· In accordance with the General Authority, the maximum price paid per Ordinary Share acquired by the Company pursuant to the Programme is to be no more than:

 

o  105 per cent. of the average of the middle market quotations for an Ordinary Share (taken from the AIM List) for the five business days immediately preceding the day on which the Ordinary Share is purchased;

 

o  the higher of the price of the last independent trade and the highest current independent bid for an Ordinary Share on the London Stock Exchange

 

· The Programme will commence on 19 January 2026 and will continue until the earlier of 19 July 2026 or until the maximum pecuniary amount has been purchased under the Programme.

 

· The purchased Ordinary Shares will be cancelled by the Company.

 

· Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volume.

 

· The Company confirms that it currently has no unpublished inside information.

 

· The Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 as it forms part of UK law pursuant to the UK's European Union (Withdrawal) Act 2018 and the Market Abuse (Amendment) (EU Exit) Regulations 2019)

 

· Any repurchase of Ordinary Shares will be announced no later than 7:30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

· There is no guarantee that the Programme will be implemented in full.

 

· As at 15 January 2026, the Company's total issued share capital consisted of 101,568,374 Ordinary Shares, with one voting right per share. The Company holds nil Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company was 101,568,374. 

 

 

For further information please contact: 

Polar Capital

Tracey Lago (Group Company Secretary)

+44 (0)20 7227 2700

Deutsche Numis - Nomad and Joint Broker

Giles Rolls

Charles Farquhar

 +44 (0)20 7260 1000

 

Camarco - PR

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

+44 (0)20 3757 4980

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAKPBBOBKDFDD
Date   Source Headline
18th Sep 202011:20 amRNSForm 8.3 - HASTINGS GROUP HOLDINGS PLC
10th Sep 202012:26 pmRNSForm 8.3 - HASTINGS GROUP
6th Aug 20203:31 pmRNSForm 8.3 - HASTINGS GROUP HOLDINGS PLC
3rd Aug 20207:00 amRNSBlock listing Interim Review
3rd Aug 20207:00 amRNSTotal Voting Rights
31st Jul 20207:30 amRNSIssue of Equity
30th Jul 20205:23 pmRNSForm 8.3 - HASTINGS GROUP HOLDINGS PLC
29th Jul 20207:00 amRNSResult of AGM
22nd Jul 20204:15 pmRNSIssue of Equity
22nd Jul 202012:10 pmRNSDirector/PDMR Shareholding
10th Jul 20202:07 pmRNSDirector/PDMR Shareholding
10th Jul 20202:06 pmRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSAuM Update
7th Jul 20208:03 amRNSHolding(s) in Company
6th Jul 202010:08 amRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSForm 8.3 - Cello Health PLC
2nd Jul 20209:19 amRNSDirector/PDMR Shareholding
1st Jul 20202:10 pmRNSIssue of Equity
1st Jul 20207:00 amRNSTotal Voting Rights
29th Jun 202010:03 amRNSDirector/PDMR Shareholding
26th Jun 20201:10 pmRNSAnnual Financial Report
25th Jun 202010:26 amRNSHolding(s) in Company
25th Jun 202010:25 amRNSDirector/PDMR Shareholding
24th Jun 20203:29 pmRNSIssue of Equity
22nd Jun 20204:04 pmRNSDividend Declaration
22nd Jun 20207:00 amRNSGroup Audited Results for year ended 31 March 2020
18th Jun 202012:08 pmRNSSecond Price Monitoring Extn
18th Jun 202012:02 pmRNSPrice Monitoring Extension
5th Jun 202010:31 amRNSDirector/PDMR Shareholding
4th Jun 20207:16 amRNSNotice of Results
1st Jun 20207:00 amRNSTotal Voting Rights
19th May 20202:00 pmRNSIssue of Equity
12th May 202010:22 amRNSDirector/PDMR Shareholding
11th May 20201:15 pmRNSDirectorate Change
6th May 202011:36 amRNSHolding(s) in Company
4th May 20201:07 pmRNSIssue of Equity
4th May 202011:24 amRNSDirector/PDMR Shareholding
15th Apr 202012:00 pmRNSFund Termination
9th Apr 20204:26 pmRNSDirectorate Change
9th Apr 202012:02 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSAuM Update
7th Apr 20204:40 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSBoard Changes
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.